Moderna’s COVID-19 Vaccine Effective Against New Variants
XTalks
JANUARY 27, 2021
The company used in vitro neutralization antibody studies to evaluate the activity of Moderna’s vaccine-generated antibodies in human sera against several variants of the novel coronavirus, including the B.1.1.7 The in vitro study evaluated the ability of mRNA-1273-generated antibodies to neutralize the new SARS-CoV-2 variants.
Let's personalize your content